Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.

Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.

To compare the effect of tocilizumab (TCZ) with other biologic therapies in improving anemia of rheumatoid arthritis (RA) patients.We compared the change of hemoglobin (Hb) levels in a cohort of 147 consecutive RA patients who were treated with biologics for more than 12 weeks. Twenty eight patients...

Full description

Bibliographic Details
Main Authors: Motomu Hashimoto, Takao Fujii, Masahide Hamaguchi, Moritoshi Furu, Hiromu Ito, Chikashi Terao, Keiichi Yamamoto, Wataru Yamamoto, Takashi Matsuo, Masato Mori, Koichiro Ohmura, Hiroshi Kawabata, Tsuneyo Mimori
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4039447?pdf=render

Internet

http://europepmc.org/articles/PMC4039447?pdf=render

Similar Items